Pharma Reaserch Prod Co Ltd (214450) — Cash Flow Quality Index
Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Quality Index of 1.89x as of December 2025. Operating cash flow of ₩61.53 Billion exceeds net income of ₩32.57 Billion, indicating high earnings quality where cash backs reported profits. Explore Pharma Reaserch Prod Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharma Reaserch Prod Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Pharma Reaserch Prod Co Ltd.
Annual Cash Flow Quality Index for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Pharma Reaserch Prod Co Ltd.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | ₩183.16 Billion | ₩165.12 Billion | ▼ -29.4% |
| 2024 | 1.57x | ₩139.88 Billion | ₩89.01 Billion | ▲ +81.9% |
| 2023 | 0.86x | ₩64.95 Billion | ₩75.18 Billion | ▼ -40.3% |
| 2022 | 1.45x | ₩59.40 Billion | ₩41.04 Billion | ▲ +3.7% |
| 2021 | 1.40x | ₩65.30 Billion | ₩46.76 Billion | ▲ +41.3% |
| 2020 | 0.99x | ₩32.39 Billion | ₩32.77 Billion | ▼ -14.5% |
| 2019 | 1.16x | ₩19.27 Billion | ₩16.67 Billion | ▲ +220.2% |
| 2018 | 0.36x | ₩5.20 Billion | ₩14.41 Billion | ▼ -45.3% |
| 2017 | 0.66x | ₩8.56 Billion | ₩12.96 Billion | ▲ +11.9% |
| 2016 | 0.59x | ₩8.16 Billion | ₩13.83 Billion | ▼ -52.6% |
| 2015 | 1.24x | ₩16.02 Billion | ₩12.88 Billion | — |